If you ask researchers in nutritional psychiatry which supplement has the best evidence in schizophrenia, the answer is usually N-acetylcysteine, almost always abbreviated NAC. It has been studied in randomised controlled trials, has a plausible mechanism tied directly to schizophrenia biology, and shows up in clinical guidelines as a reasonable add-on for selected patients. It is also widely misunderstood, both by people who dismiss it as a "supplement" and by people who present it as a miracle.
NAC is a glutathione precursor and glutamate modulator with multiple randomised trials in schizophrenia showing modest but real benefits — particularly for negative symptoms — when added to standard antipsychotic treatment.
What NAC actually is
N-acetylcysteine is a modified form of the amino acid cysteine. It is FDA-approved as a prescription medication (Mucomyst) for treating acetaminophen overdose and as a mucolytic for some lung conditions. It is also widely sold over the counter as a dietary supplement. In the brain, NAC does several relevant things:
- Provides cysteine for the synthesis of glutathione, the main intracellular antioxidant
- Modulates glutamate release through the cystine-glutamate antiporter
- Reduces neuroinflammation
- Increases brain levels of glutathione, which are reduced in schizophrenia
Each of these touches an axis directly relevant to modern theories of schizophrenia (oxidative stress, glutamate dysregulation, neuroinflammation), which is one reason NAC has attracted serious attention.
The trials
The landmark study is a 2008 trial by Berk and colleagues published in Biological Psychiatry (available via PubMed). It randomised 140 patients with chronic schizophrenia to either NAC 2 grams per day or placebo, added to their existing antipsychotic, for six months. The NAC group had statistically significant improvements in total symptom scores and in the negative-symptom subscale, with effects emerging gradually over months.
Subsequent randomised trials have largely supported this picture:
- Improvements in negative symptoms and general psychopathology, with smaller effects on positive symptoms
- Improvements in some cognitive measures (mismatch negativity, an electrophysiological measure of auditory processing)
- Benefits typically appearing after 8–24 weeks of treatment
A meta-analysis published in Schizophrenia Research and indexed on PubMed pooled multiple trials and concluded that NAC produces a modest but reproducible benefit on total symptom scores in schizophrenia when used as an add-on.
Where the limits are
- The effects are modest, not dramatic — NAC doesn't usually reorganise a patient's symptom picture the way starting an effective antipsychotic might
- Onset is slow; patients and families expecting fast change are often disappointed
- NAC does not appear to substitute for antipsychotic medication in studies done so far
- Results across trials vary, and not every patient responds
How NAC is typically used
In schizophrenia trials, the most common dose has been 2 grams per day (often 1 gram twice daily) added to standard antipsychotic treatment, for at least 6 months. Some studies have used 1.2 grams; some have explored higher doses for early psychosis. Anyone considering NAC should treat it as a real treatment trial: define what you are hoping will change, track it, and reassess at month 6.
Side effects and tolerability
NAC is generally very well tolerated. The most common issues are:
- Mild nausea, gas, or diarrhoea (often improves with food or split dosing)
- Sulphurous odour or taste — NAC contains sulphur
- Rare allergic reactions
It can increase bleeding risk slightly when combined with anticoagulants, and there are theoretical interactions with nitrate medications. As always, tell your prescriber.
NAC is not the right approach for an acute psychotic crisis. If symptoms escalate quickly, follow your relapse plan and contact your psychiatric team or a crisis line — see our guide on when to call 911 for a mental health crisis.
Where it fits in a treatment plan
NAC is best thought of as one of several reasonable add-on strategies for people with schizophrenia who have lingering negative or cognitive symptoms despite an effective antipsychotic. It belongs alongside other evidence-based interventions, including:
- Regular aerobic exercise
- CBT for negative symptoms
- Cognitive remediation
- Targeted social skills and supported employment programmes
The right comparison is not "NAC vs. nothing" but "this whole plan including NAC vs. this whole plan without it."
Quality of supplements
Because NAC is sold as a supplement in most US states, quality varies. Look for products that are independently tested (USP, NSF, or ConsumerLab certified) and ideally specify exact mg per capsule. Pharmaceutical NAC (used for IV acetaminophen overdose) is highly regulated; over-the-counter NAC is not.
The honest summary
Among everything sold as "nutritional psychiatry," NAC has the most credible evidence in schizophrenia. The effect is modest, the onset is slow, and it is an add-on rather than a replacement. For someone with persistent negative or cognitive symptoms, a six-month structured trial of 2 grams per day, with a clinician's input and clear endpoints, is a reasonable conversation to have. It is not a miracle and not snake oil — it is a real, well-studied, modestly helpful adjunct.
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a qualified mental health professional. If you or someone you know is in crisis, call or text 988 in the US, or your local emergency number.